Jump Financial, LLC Chinook Therapeutics, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$18.63 - $27.35 $41,619 - $61,099	2,234 Added 5.12%	45,868 $1.2 Million
Q3 2022 Nov 07, 2022	BUY	$17.51 - $23.37 $587,898 - $784,647	33,575 Added 333.78%	43,634 $858,000
Q2 2022 Aug 09, 2022	SELL	$12.59 - $18.8 $228,395 - $341,050	-18,141 Reduced 64.33%	10,059 $176,000
Q1 2022 May 12, 2022	BUY	$12.02 - $16.69 $338,964 - $470,658	28,200 New	28,200 $461,000
Q4 2021 Feb 10, 2022	SELL	$10.69 - $16.83 $181,730 - $286,110	-17,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.5 - $14.86 $195,500 - $252,620	17,000 New	17,000 $217,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.